| Net income (loss) | -4.58M |
| Depreciation and amortization | 1.04M |
| Provision for doubtful accounts | 115K |
| Stock-based compensation expense | 125K |
| Change in fair value of warrant liability | -2.57M |
| Accounts receivable | 911K |
| Note receivable | |
| Prepaid expenses and other | -16K |
| Accounts payable and accrued liabilities | 728K |
| Deferred revenue | 33K |
| Net cash (used in) provided by operating activities | |
| Capital expenditures | -478K |
| Issuance of notes receivable | |
| Proceeds from notes receivable | |
| Acquisitions, net of cash acquired | |
| Purchases of intangible assets | |
| Net cash used in investing activities | |
| Proceeds from the exercise of warrants | |
| Proceeds from the exercise of options | |
| Proceeds from the public offering of common stock | |
| Payment of revolving credit facility | |
| Proceeds from revolving credit facility | |
| Payment of financing related costs | -491K |
| Net cash provided by financing activities | |
| Net increase in cash and cash equivalents | |
| Cash and cash equivalents, beginning of the period | 2.44M |
| Cash and cash equivalents, end of the period | 2.29M |
| Interest paid | 140K |
| Income taxes paid | 0 |